A role for platelets in metabolic reprogramming of tumor-associated macrophages
Frontiers in Physiology · 24.08.2023 · 14
DOI: 10.3389/fphys.2023.1250982 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Physiology, online erschienen am 24.08.2023. Verfasst von Ying Kang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, School of Pharmacy, College of Health and Human Sciences, North Dakota State University, Fargo, ND, United Sta…. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Cancer incidence and mortality are growing worldwide. With a lack of optimal treatments across many cancer types, there is an unmet need for the development of novel treatment strategies for cancer. One approach is to leverage the immune system for its ability to survey for cancer cells. However, cancer cells evolve to evade immune surveillance by establishing a tumor microenvironment (TME) that is marked by remarkable immune suppression. Macrophages are a predominant immune cell within the TME and have a major role in regulating tumor growth. In the TME, macrophages undergo metabolic reprogramming and differentiate into tumor-associated macrophages (TAM), which typically assume an immunosuppressive phenotype supportive of tumor growth. However, the plasticity of macrophage biology offers the possibility that macrophages may be promising therapeutic targets. Among the many determinants in the TME that may shape TAM biology, platelets can also contribute to cancer growth and to maintaining immune suppression. Platelets communicate with immune cells including macrophages through the secretion of immune mediators and cell-cell interaction. In other diseases, altering platelet secretion and cell-cell communication has been shown to reprogram macrophages and ameliorate inflammation. Thus, intervening on platelet-macrophage biology may be a novel therapeutic strategy for cancer. This review discusses our current understanding of the interaction between platelets and macrophages in the TME and details possible strategies for reprogramming macrophages into an anti-tumor phenotype for suppressing tumor growth.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, School of Pharmacy, College of Health and Human Sciences, North Dakota State University, Fargo, ND, United States.
- Department of Medicine, Division of Hematology-Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
- Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Förderung
- NCI NIH HHS
Zitieren
APA
Kang, Y., Amoafo, E. B., Entsie, P., Beatty, G. L., & Liverani, E. (2023). A role for platelets in metabolic reprogramming of tumor-associated macrophages. Frontiers in Physiology, 14. https://doi.org/10.3389/fphys.2023.1250982
Vancouver
Kang Y, Amoafo EB, Entsie P, Beatty GL, Liverani E. A role for platelets in metabolic reprogramming of tumor-associated macrophages. Frontiers in Physiology. 2023;14. doi:10.3389/fphys.2023.1250982
BibTeX
@article{Kang2023,
author = {Kang, Ying and Amoafo, Emmanuel Boadi and Entsie, Philomena and Beatty, Gregory L and Liverani, Elisabetta},
title = {A role for platelets in metabolic reprogramming of tumor-associated macrophages},
journal = {Frontiers in Physiology},
year = {2023},
volume = {14},
doi = {10.3389/fphys.2023.1250982}
}
EUVIMED